STINGel: Controlled release of a cyclic dinucleotide for enhanced cancer immunotherapy.
about
STINGel: Controlled release of a cyclic dinucleotide for enhanced cancer immunotherapy.
description
2018 nî lūn-bûn
@nan
2018年の論文
@ja
2018年学术文章
@wuu
2018年学术文章
@zh
2018年学术文章
@zh-cn
2018年学术文章
@zh-hans
2018年学术文章
@zh-my
2018年学术文章
@zh-sg
2018年學術文章
@yue
2018年學術文章
@zh-hant
name
STINGel: Controlled release of a cyclic dinucleotide for enhanced cancer immunotherapy.
@en
STINGel: Controlled release of a cyclic dinucleotide for enhanced cancer immunotherapy.
@nl
type
label
STINGel: Controlled release of a cyclic dinucleotide for enhanced cancer immunotherapy.
@en
STINGel: Controlled release of a cyclic dinucleotide for enhanced cancer immunotherapy.
@nl
prefLabel
STINGel: Controlled release of a cyclic dinucleotide for enhanced cancer immunotherapy.
@en
STINGel: Controlled release of a cyclic dinucleotide for enhanced cancer immunotherapy.
@nl
P2093
P2860
P1433
P1476
STINGel: Controlled release of a cyclic dinucleotide for enhanced cancer immunotherapy
@en
P2093
Andrew G Sikora
David G Leach
Jeffrey D Hartgerink
Neeraja Dharmaraj
Stacey L Piotrowski
Tania L Lopez-Silva
P2860
P356
10.1016/J.BIOMATERIALS.2018.01.035
P50
P577
2018-02-06T00:00:00Z